Back
Results - Announcements
Suraksha Diagnostic Ltd consolidated sales up 7.66% on year in Q2FY2026, net profit jumped 108.60%
12-Aug-2026, 08:06
Suraksha Diagnostic Ltd share price declined by 2.86% to Rs 258.05. The Company's net profit saw a strong growth of 108.60% to Rs 12.85 crore, while revenue from operations improved marginally 7.66% to Rs 87.65 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 72411.07 crore, climbing 10.23%. It has inched up 2.96% over last one week and surged by 17.34% in last one month while the market capitalization of Suraksha Diagnostic Ltd has marginally improved by 7.64% and 10.58% in the same period respectively. Profit before tax (PBT) of Suraksha Diagnostic Ltd stood at Rs 16.53 crore in Q2 FY26, rallying 32.56% year-on-year, and surging by 65.63% quarter-on-quarter. EBITDA came in at Rs 29 crore, jumping 28.50% YoY and expanding by 24.47% sequentially. Total expenses posted a minor rise of 0.28% to Rs 68.49 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 10.0 crore, easing 1.57% YoY, while employee benefits expense was at Rs 14.41 crore, inching up 5.41% YoY. For the TTM ended FY26, revenue from operations grew 15.26% to Rs 252.09 crore, while net profit soared by 33.94% to Rs 30.98 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 6822% to Rs 77.39 crore, and PBT witnessed a strong rise of 31.67% to Rs 41.41 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 63.36 crore in FY26, as against Rs 60.48 crore in FY25. Suraksha Diagnostic Ltd tumbled by 13.11% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.04% during the same period.
Suraksha Diagnostic Ltd share price declined by 2.86% to Rs 258.05. The Company's net profit saw a strong growth of 108.60% to Rs 12.85 crore, while revenue from operations improved marginally 7.66% to Rs 87.65 crore in Q2FY26 over Q1FY26. The market capitalization of Healthcare Service Provider industry group stocks on BSE stood at Rs 72411.07 crore, climbing 10.23%. It has inched up 2.96% over last one week and surged by 17.34% in last one month while the market capitalization of Suraksha Diagnostic Ltd has marginally improved by 7.64% and 10.58% in the same period respectively. Profit before tax (PBT) of Suraksha Diagnostic Ltd stood at Rs 16.53 crore in Q2 FY26, rallying 32.56% year-on-year, and surging by 65.63% quarter-on-quarter. EBITDA came in at Rs 29 crore, jumping 28.50% YoY and expanding by 24.47% sequentially. Total expenses posted a minor rise of 0.28% to Rs 68.49 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 10.0 crore, easing 1.57% YoY, while employee benefits expense was at Rs 14.41 crore, inching up 5.41% YoY. For the TTM ended FY26, revenue from operations grew 15.26% to Rs 252.09 crore, while net profit soared by 33.94% to Rs 30.98 crore, compared to previous TTM. EBITDA witnessed a strong improvement of 6822% to Rs 77.39 crore, and PBT witnessed a strong rise of 31.67% to Rs 41.41 crore compared to previous TTM. The company's consolidated net cash flow from operating activities stood at Rs 63.36 crore in FY26, as against Rs 60.48 crore in FY25. Suraksha Diagnostic Ltd tumbled by 13.11% in last one year, underperforming the benchmark BSE Sensex which has eased by 3.04% during the same period.